MedPath

Leflunomide

Generic Name
Leflunomide
Brand Names
Arava, Leflunomide medac, Leflunomide Zentiva (previously Leflunomide Winthrop), Leflunomide ratiopharm
Drug Type
Small Molecule
Chemical Formula
C12H9F3N2O2
CAS Number
75706-12-6
Unique Ingredient Identifier
G162GK9U4W

Overview

Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD (disease-modifying antirheumatic drug) class of drugs, which are chemically and pharmacologically very heterogeneous. Leflunomide was approved by FDA and in many other countries (e.g., Canada, Europe) in 1999.

Indication

For the management of the signs and symptoms of active rheumatoid arthritis (RA) to improve physical function and to slow the progression of structural damage associated with the disease. Has also been used for the prevention of acute and chronic rejection in recipients of solid organ trasnplants and is designated by the FDA as an orphan drug for this use.

Associated Conditions

  • Juvenile Idiopathic Arthritis (JIA)
  • Rheumatoid Arthritis

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/11
Phase 1
Not yet recruiting
2024/12/03
N/A
Active, not recruiting
2024/08/07
Phase 2
Recruiting
2024/06/12
Phase 1
Recruiting
City of Hope Medical Center
2024/01/29
Phase 2
Recruiting
N.N. Petrov National Medical Research Center of Oncology
2024/01/29
Phase 1
Not yet recruiting
International Bio service
2023/07/10
Not Applicable
Recruiting
2023/07/10
Phase 1
Recruiting
2023/03/29
Not Applicable
Recruiting
2023/03/29
Not Applicable
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
KVK-Tech, Inc.
10702-277
ORAL
10 mg in 1 1
6/23/2025
Bryant Ranch Prepack
71335-2256
ORAL
20 mg in 1 1
4/30/2021
Zydus Lifesciences Limited
70771-1491
ORAL
10 mg in 1 1
9/15/2023
AvKARE
42291-421
ORAL
20 mg in 1 1
1/9/2024
Bryant Ranch Prepack
63629-9728
ORAL
10 mg in 1 1
4/30/2021
KVK-Tech, Inc.
10702-278
Oral, ORAL
20 mg in 1 1
6/23/2025
Chartwell RX, LLC
62135-794
ORAL
20 mg in 1 1
10/31/2023
sanofi-aventis U.S. LLC
0088-2161
ORAL
20 mg in 1 1
10/4/2022
Apotex Corp.
60505-2503
ORAL
20 mg in 1 1
12/14/2023
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
23155-043
ORAL
10 mg in 1 1
4/19/2022

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
ARAVA TABLET 20 mg
SIN11400P
TABLET, FILM COATED
20 mg
10/14/2000
LEFLUNOMIDE MEVON FILM-COATED TABLETS 20 MG
SIN15252P
TABLET, FILM COATED
20.00 MG
5/31/2017
ARAVA TABLET 100 mg
SIN11401P
TABLET, FILM COATED
100 mg
10/14/2000
BAGEDA FILM-COATED TABLET 20MG
SIN17108P
TABLET, FILM COATED
20.000mg
10/8/2024

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Leflunomide Tablets
国药准字H20090330
化学药品
片剂
7/29/2019
Leflunomide Tablets
国药准字H20223501
化学药品
片剂
2/9/2023
Leflunomide Tablets
国药准字H20080054
化学药品
片剂
10/27/2022
Leflunomide Tablets
国药准字HJ20240074
化学药品
片剂
7/30/2024
Leflunomide Tablets
国药准字HJ20240075
化学药品
片剂
7/30/2024
Leflunomide Tablets
国药准字H20060034
化学药品
片剂
6/5/2020
Leflunomide Tablets
国药准字H20203195
化学药品
片剂
5/7/2020
Leflunomide Tablets
国药准字H20080420
化学药品
片剂
5/23/2023
Leflunomide Tablets
国药准字H20050129
化学药品
片剂
6/5/2020
Leflunomide Tablets
国药准字H20050175
化学药品
片剂(薄膜衣片)
5/19/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.